A phase III randomized open-label comparative study of standard whole brain radiation therapy with or without RSR13 [efaproxiral] in patients with brain metastases.

Trial Profile

A phase III randomized open-label comparative study of standard whole brain radiation therapy with or without RSR13 [efaproxiral] in patients with brain metastases.

Completed
Phase of Trial: Phase III

Latest Information Update: 09 May 2013

At a glance

  • Drugs Efaproxiral (Primary)
  • Indications Cancer metastases
  • Focus Registrational; Therapeutic Use
  • Most Recent Events

    • 15 Nov 2007 Status changed from in progress to completed.
    • 28 Sep 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top